Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
10 p, 676.5 KB Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients / Levtchenko, Elena (Department of Pediatrics, University Hospitals Leuven Campus Gasthuisberg (Bélgica)) ; Servais, Aude (Nephrology and Transplantation Department, Hôpital Necker Enfants Malades APHP (França)) ; Hulton, Sally A (Department of Nephrology, Birmingham Women's and Children's Hospital NHS Foundation Trust (Regne Unit)) ; Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron) ; Emma, Francesco (Ospedale Pediatrico Bambino Gesù-IRCCS (Itàlia)) ; Game, David S (Department of Renal Medicine, Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ; Lange, Karin (Hannover Medical School (Alemanya)) ; Lapatto, Risto (Department of Pediatrics, Children's Hospital, Helsinki University Hospital and University of Helsinki) ; Liang, Hong (CHNO des Quinze-Vingts, IHU ForeSight (França)) ; Sberro-Soussan, Rebecca (Paris Descartes University-Sorbonne Paris Cité) ; Topaloglu, Rezan (Hacettepe University (Turquia)) ; Das, Anibh M (Clinic for Paediatric Kidney-, Liver- and Metabolic Diseases (Alemanya)) ; Webb, Nicholas J A (Department of Paediatric Nephrology, University of Manchester) ; Wanner, Christoph (University Hospital Würzburg (Alemanya)) ; Universitat Autònoma de Barcelona
Cystinosis, a rare autosomal recessive lysosomal storage disorder, results in an abnormal accumulation of the amino acid cystine in multiple organs and tissues of the body. Renal symptoms typically develop in the first few months of life, with extra-renal manifestations becoming apparent over the next 10-20 years, which require coordinated multidisciplinary care. [...]
2022 - 10.1093/ckj/sfac099
Clinical Kidney Journal, Vol. 15 (april 2022) , p. 1675-1684  
2.
12 p, 1.5 MB Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease / Webb, Nicholas J. A. (Royal Manchester Children's Hospital, Manchester, UK) ; Lerner, Gary (Keck School of Medicine-Children's Hospital Los Angeles, USA) ; Warady, Bradley A. (Children's Mercy Hospital, Kansas City, USA.) ; Dell, Katherine M. (Cleveland Clinic Children's, USA) ; Greenbaum, Larry A. (Emory School of Medicine and Children's Healthcare of Atlanta, USA.) ; Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron) ; Hoppe, Bernd (University Hospital Bonn (Bonn, Alemanya)) ; Linde, Peter (AbbVie Inc., North Chicago, USA) ; Lee, Ho-Jin (AbbVie Inc., North Chicago, USA) ; Eldred, Ann (AbbVie Inc., North Chicago, USA) ; Dufek, Matthew B. (AbbVie Inc., North Chicago, USA) ; Universitat Autònoma de Barcelona
Elevated intact parathyroid hormone (iPTH) levels can contribute to morbidity and mortality in children with chronic kidney disease (CKD). We evaluated the pharmacokinetics, efficacy, and safety of oral paricalcitol in reducing iPTH levels in children with stages 3-5 CKD. [...]
2017 - 10.1007/s00467-017-3579-6
Pediatric Nephrology, Vol. 32 (march 2017) , p. 1221-1232  

See also: similar author names
1 Webb, N.
1 Webb, Nicholas J A
1 Webb, Nicholas J. A.
1 Webb, Nicole M.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.